Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

With a longtime vaccine skeptic serving as the country’s top health official, the movement is likely to make further inroads.

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

This revolution is being powered by RNA technology—and Canada is uniquely positioned to lead it. While the swift development of COVID-19 vaccines appeared to be a sudden scientific triumph ...

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...